Immunotherapy and Chemotherapy Versus Sleep Disturbances for NSCLC Patients.

Pavlos ZarogoulidisDimitrios PetridisChristoforos KosmidisKonstantinos SapalidisLila NenaDimitrios MatthaiosΚonstantinos PorpodisPaschalis KakavelasPaschalis Steiropoulos

Published in: Current oncology (Toronto, Ont.) (2023)

Immunotherapy drugs on their own do not induce sleep disturbances and, through treatment response, alleviate sleep disturbances in lung cancer patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
small cell lung cancer
physical activity
prognostic factors
peritoneal dialysis
sleep quality
radiation therapy
patient reported outcomes